« FDA Approvals - The Year In Review: Allergan (Sharewatch) Best known for its | Main | Cloning policy change comes late for farmer (David Dishneau / »

FDA Approvals - Oscient Pharmaceuticals Amends FACTIVE License Agreement with LG Life Sciences


Oscient Pharmaceuticals Amends FACTIVE License Agreement with LG Life Sciences (Business Wire via Yahoo! Finance)
WALTHAM, Mass.----Oscient Pharmaceuticals Corporation has amended its license and option agreement with LG Life Sciences, Ltd. for the Company's antibiotic product, FACTIVE tablets.

NovaDel Closes on $14 Million Financing (Business Wire via Yahoo! Finance)
FLEMINGTON, N.J.----NovaDel Pharma Inc. announced today that it has completed the previously announced sale of 9,823,983 shares of the Company's common stock to new and existing investors to raise approximately $14 million in gross proceeds in a common stock private equity offering.

Bradley Pharmaceuticals Announces Launch of Authorized Generic of Pamine(R) (methscopolamine bromide) (FinanzNachrichten)
FAIRFIELD, N.J., Dec. 29 /PRNewswire-FirstCall/ -- Bradley Pharmaceuticals, ( Nachrichten ) Inc. reported today that A. Aarons, Inc., a subsidiary of Bradley Pharmaceuticals, has announced the launch of methscopolamine bromide tablets, an authorized generic of the Company's Pamine(R) tablets.
 

©2006 FDA-News.com. All rights reserved.